FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Jay Skyler

Research Profile

Disorders

Chemicals & Drugs

Procedures

Glucose Tolerance Test

Geographic Areas

United States

Anatomy

Co-author Network

Publications

TOP 3
Alberto Pugliese; Jay S Skyler
George s. Eisenbarth: insulin and type 1 diabetes.
Jay S Skyler
The year in immune intervention for type 1 diabetes.
James K Rustad; Jay S Skyler; Ricardo Caceda; Alan Delamater; Norma S Kenyon; Della Matheson; Dominique L Musselman; Charles B Nemeroff
Decision-making in diabetes mellitus type 1.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Jay Skyler (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Alberto Pugliese; Jay S Skyler
George s. Eisenbarth: insulin and type 1 diabetes.
Diabetes care 2013;36(6):1437-42.
2013: Jay S Skyler
The year in immune intervention for type 1 diabetes.
Diabetes technology & therapeutics 2013;15 Suppl 1():S88-95.
2013: James K Rustad; Jay S Skyler; Ricardo Caceda; Alan Delamater; Norma S Kenyon; Della Matheson; Dominique L Musselman; Charles B Nemeroff
Decision-making in diabetes mellitus type 1.
The Journal of neuropsychiatry and clinical neurosciences 2013;25(1):40-50.
2012: D Han; Norma S Kenyon; D Matheson; Jay S Skyler; J Wen; Xiaodong Cai; Z Chen
Innate and adaptive immune gene expression profiles as biomarkers in human type 1 diabetes.
Clinical and experimental immunology 2012;170(2):131-8.
2012: Ping Xu; Craig A Beam; David Cuthbertson; Jeffrey P Krischer; Jay S Skyler; Jay M Sosenko
Prognostic accuracy of immunologic and metabolic markers for type 1 diabetes in a high-risk population: receiver operating characteristic analysis.
Diabetes care 2012;35(10):1975-80.
2012: Carla J Greenbaum; Kevan C Herold; Heidi Krause-Steinrauf; John M Lachin; Paula McGee; Jerry P Palmer; Mark D Pescovitz; Jay S Skyler; Jay M Sosenko; Craig A Beam; David Boulware; Stephen E Gitelman; Peter A Gottlieb
Fall in C-peptide during first 2 years from diagnosis: evidence of at least two distinct phases from composite Type 1 Diabetes TrialNet data.
Diabetes 2012;61(8):2066-73.
2012: Gaetano Faleo; Carmen Fotino; R. Damaris Molano; Judith Molina; Camillo Ricordi; Jay S Skyler; Oliver Umland; Susana Villate; Elsie Zahr-Akrawi; Allison L Bayer; Nicola Bocca; Antonello Pileggi
Prevention of autoimmune diabetes and induction of β-cell proliferation in NOD mice by hyperbaric oxygen therapy.
Diabetes 2012;61(7):1769-78.
2012: Jay M Sosenko; Craig A Beam; David C Boulware; Catherine Cowie; David Cuthbertson; Carla J Greenbaum; Jeffrey P Krischer; Jeffrey L Mahon; Jerry P Palmer; Lisa Rafkin-Mervis; Jay S Skyler
The application of the diabetes prevention trial-type 1 risk score for identifying a preclinical state of type 1 diabetes.
Diabetes care 2012;35(7):1552-5.
2012: Jay M Sosenko; Kevan C Herold; Jerry P Palmer; Jay S Skyler
The metabolic progression to type 1 diabetes as indicated by serial oral glucose tolerance testing in the Diabetes Prevention Trial-type 1.
Diabetes 2012;61(6):1331-7.
2012: Liping Yu; Craig A Beam; Polly J Bingley; David C Boulware; George S Eisenbarth; Carla J Greenbaum; John C Hutton; Jeffrey P Krischer; Jeffrey L Mahon; Jay S Skyler; Jay M Sosenko; Janet M Wenzlau
Zinc transporter-8 autoantibodies improve prediction of type 1 diabetes in relatives positive for the standard biochemical autoantibodies.
Diabetes care 2012;35(6):1213-8.
2011: Mark D Pescovitz; Jay S Skyler; Troy R Torgerson; Adriana Weinberg; Jennifer Canniff; Carla Greenbaum; Kevan C Herold; Heidi Krause-Steinrauf; John M Lachin; Paula McGee; Elizabeth Ocheltree; Hans D Ochs
Effect of rituximab on human in vivo antibody immune responses.
The Journal of allergy and clinical immunology 2011;128(6):1295-1302.e5.
2011: Jeffrey L Mahon; Santica M Marcovina; Jerry P Palmer; Jay S Skyler; William E Winter; Craig A Beam; David C Boulware; Jeffrey P Krischer
Comparison of two insulin assays for first-phase insulin release in type 1 diabetes prediction and prevention studies.
Clinica chimica acta; international journal of clinical chemistry 2011;412(23-24):2128-31.
2011: Jay M Sosenko; Liping Yu; David Cuthbertson; George Eisenbarth; Jeffrey P Krischer; Tihamer Orban; Jerry P Palmer; Desmond A Schatz; Jay S Skyler
A longitudinal study of GAD65 and ICA512 autoantibodies during the progression to type 1 diabetes in Diabetes Prevention Trial-Type 1 (DPT-1) participants.
Diabetes care 2011;34(11):2435-7.
2011: Kendra Vehik; Craig A Beam; Michael J Haller; Jeffrey P Krischer; Jeffrey L Mahon; Desmond A Schatz; Jay S Skyler; Jay M Sosenko
Development of autoantibodies in the TrialNet Natural History Study.
Diabetes care 2011;34(9):1897-901.
2011: Jay M Sosenko; Craig A Beam; David C Boulware; Catherine Cowie; David Cuthbertson; Carla J Greenbaum; Jeffrey P Krischer; Jeffrey L Mahon; Jerry P Palmer; Lisa Rafkin-Mervis; Jay S Skyler
Validation of the Diabetes Prevention Trial-Type 1 Risk Score in the TrialNet Natural History Study.
Diabetes care 2011;34(8):1785-7.
2011: Tihamer Orban; Philip Raskin; Henry Rodriguez; William E Russell; Desmond Schatz; Jay S Skyler; Diane Wherrett; Darrell M Wilson; Dorothy J Becker; Brian Bundy; Linda A DiMeglio; Stephen E Gitelman; Robin Goland; Peter A Gottlieb; Carla J Greenbaum; Jeffrey P Krischer; Jennifer B Marks; Roshanak Monzavi; Antoinette Moran
Co-stimulation modulation with abatacept in patients with recent-onset type 1 diabetes: a randomised, double-blind, placebo-controlled trial.
Lancet 2011;378(9789):412-9.
2011: Diane K Wherrett; Darrell M Wilson; Dorothy J Becker; Brian Bundy; Linda A DiMeglio; Stephen E Gitelman; Robin Goland; Peter A Gottlieb; Carla J Greenbaum; Kevan C Herold; Jeffrey P Krischer; Jennifer B Marks; Roshanak Monzavi; Antoinette Moran; Tihamer Orban; Jerry P Palmer; Philip Raskin; Henry Rodriguez; Desmond Schatz; Jay S Skyler
Antigen-based therapy with glutamic acid decarboxylase (GAD) vaccine in patients with recent-onset type 1 diabetes: a randomised double-blind trial.
Lancet 2011;378(9788):319-27.
2011: Dongmei Han; Carlos A Leyva; Della Matheson; Davide Mineo; Shari Cayetano; Bonnie B Blomberg; Ana Hernandez; Luigi F Meneghini; Gloria Allende; Jay S Skyler; Rodolfo Alejandro; Alberto Pugliese; Norma S Kenyon
Immune profiling by multiple gene expression analysis in patients at-risk and with type 1 diabetes.
Clinical immunology (Orlando, Fla.) 2011;139(3):290-301.
2011: Jay M Sosenko; Jeffrey L Mahon; Lisa Rafkin-Mervis; John M Lachin; Heidi Krause-Steinrauf; Jeffrey P Krischer; David Cuthbertson; Jerry P Palmer; Clinton Thompson; Carla J Greenbaum; Jay S Skyler
A comparison of the baseline metabolic profiles between Diabetes Prevention Trial-Type 1 and TrialNet Natural History Study participants.
Pediatric diabetes 2011;12(2):85-90.
2011: Jay S Skyler
Immune intervention for type 1 diabetes mellitus.
International journal of clinical practice. Supplement 2011;(170):61-70.
2011: John M Lachin; Paula L McGee; Jerry Palmer; Mark D Pescovitz; Jay S Skyler; Peter Gottlieb; Carla J Greenbaum
Sample size requirements for studies of treatment effects on beta-cell function in newly diagnosed type 1 diabetes.
PloS one 2011;6(11):e26471.
2011: Jay S Skyler; Camillo Ricordi
Stopping type 1 diabetes: attempts to prevent or cure type 1 diabetes in man.
Diabetes 2011;60(1):1-8.
2010: Ping Xu; Yougui Wu; Yiliang Zhu; Getachew Dagne; Giffe Johnson; David Cuthbertson; Jeffrey P Krischer; Jay M Sosenko; Jay S Skyler
Prognostic performance of metabolic indexes in predicting onset of type 1 diabetes.
Diabetes care 2010;33(12):2508-13.
2010: Jay S Skyler
Glycemia and cardiovascular diseases in type 2 diabetes.
Journal of internal medicine 2010;268(5):468-70.
2010: Jay M Sosenko; Jay S Skyler; Jeffrey P Krischer; Carla J Greenbaum; Jeffrey L Mahon; Lisa Rafkin-Mervis; David Cuthbertson; Catherine Cowie; Kevan C Herold; George Eisenbarth; Jerry P Palmer
Glucose excursions between states of glycemia with progression to type 1 diabetes in the diabetes prevention trial-type 1 (DPT-1).
Diabetes 2010;59(10):2386-9.
2010: Jay S Skyler
Continuous subcutaneous insulin infusion--an historical perspective.
Diabetes technology & therapeutics 2010;12 Suppl 1():S5-9.
2010: Peter A Gottlieb; Scott Quinlan; Heidi Krause-Steinrauf; Carla J Greenbaum; Darrell M Wilson; Henry Rodriguez; Desmond A Schatz; Antoinette M Moran; John M Lachin; Jay S Skyler
Failure to preserve beta-cell function with mycophenolate mofetil and daclizumab combined therapy in patients with new- onset type 1 diabetes.
Diabetes care 2010;33(4):826-32.
2010: Jay M Sosenko; Jerry P Palmer; Lisa Rafkin-Mervis; Jeffrey P Krischer; David Cuthbertson; Carla J Greenbaum; George Eisenbarth; Jay S Skyler
Trends of earlier and later responses of C-peptide to oral glucose challenges with progression to type 1 diabetes in diabetes prevention trial-type 1 participants.
Diabetes care 2010;33(3):620-5.
2010: Ele Ferrannini; Andrea Mari; Valentina Nofrate; Jay M Sosenko; Jay S Skyler
Progression to diabetes in relatives of type 1 diabetic patients: mechanisms and mode of onset.
Diabetes 2010;59(3):679-85.
2010: P Aschner; E Horton; L A Leiter; N Munro; Jay S Skyler
Practical steps to improving the management of type 1 diabetes: recommendations from the Global Partnership for Effective Diabetes Management.
International journal of clinical practice 2010;64(3):305-15.
2010: Jay S Skyler
Immunomodulation for type 1 diabetes mellitus.
International journal of clinical practice. Supplement 2010;(166):59-63.
2009: Tihamer Orban; Jay M Sosenko; David Cuthbertson; Jeffrey P Krischer; Jay S Skyler; Richard Jackson; Liping Yu; Jerry P Palmer; Desmond Schatz; George Eisenbarth
Pancreatic islet autoantibodies as predictors of type 1 diabetes in the Diabetes Prevention Trial-Type 1.
Diabetes care 2009;32(12):2269-74.
2009: Mark D Pescovitz; Carla J Greenbaum; Heidi Krause-Steinrauf; Dorothy J Becker; Stephen E Gitelman; Robin Goland; Peter A Gottlieb; Jennifer B Marks; Paula F McGee; Antoinette M Moran; Philip Raskin; Henry Rodriguez; Desmond A Schatz; Diane Wherrett; Darrell M Wilson; John M Lachin; Jay S Skyler
Rituximab, B-lymphocyte depletion, and preservation of beta-cell function.
The New England journal of medicine 2009;361(22):2143-52.
2009: Simona Cernea; Itamar Raz; Kevan C Herold; Boaz Hirshberg; Bart O Roep; Desmond A Schatz; G Alexander Fleming; Paolo Pozzilli; Randie Little; Nanette C Schloot; richard leslie; Jay S Skyler; Jerry P Palmer
Challenges in developing endpoints for type 1 diabetes intervention studies.
Diabetes/metabolism research and reviews 2009;25(8):694-704.
2009: Jay M Sosenko; Jerry P Palmer; Lisa Rafkin-Mervis; Jeffrey P Krischer; David Cuthbertson; Jeffrey L Mahon; Carla J Greenbaum; Catherine Cowie; Jay S Skyler
Incident dysglycemia and progression to type 1 diabetes among participants in the Diabetes Prevention Trial-Type 1.
Diabetes care 2009;32(9):1603-7.
2009: Satish K Garg; Irl B Hirsch; Jay S Skyler
Insulin glargine and cancer--an unsubstantiated allegation.
Diabetes technology & therapeutics 2009;11(8):473-6.
2009: Jay S Skyler
Continuous glucose monitoring: an overview of its development.
Diabetes technology & therapeutics 2009;11 Suppl 1():S5-10.
2009: Jeffrey L Mahon; Jay M Sosenko; Lisa Rafkin-Mervis; Heidi Krause-Steinrauf; John M Lachin; Clinton Thompson; Polly J Bingley; Ezio Bonifacio; Jerry P Palmer; George S Eisenbarth; Joseph Wolfsdorf; Jay S Skyler
The TrialNet Natural History Study of the Development of Type 1 Diabetes: objectives, design, and initial results.
Pediatric diabetes 2009;10(2):97-104.
2009: Jay S Skyler
CGM--a technology in evolution.
Diabetes technology & therapeutics 2009;11(2):63-4.
2009: Jay S Skyler; Richard Bergenstal; Robert O Bonow; John B Buse; Prakash Deedwania; Edwin A M Gale; Barbara V Howard; M Sue Kirkman; Mikhail Kosiborod; Peter Reaven; Robert S Sherwin
Intensive glycemic control and the prevention of cardiovascular events: implications of the ACCORD, ADVANCE, and VA Diabetes Trials: a position statement of the American Diabetes Association and a Scientific Statement of the American College of Cardiology Foundation and the American Heart Association.
Journal of the American College of Cardiology 2009;53(3):298-304.
2009: Jay S Skyler; Richard Bergenstal; Robert O Bonow; John B Buse; Prakash Deedwania; Edwin A M Gale; Barbara V Howard; M Sue Kirkman; Mikhail Kosiborod; Peter Reaven; Robert S Sherwin
Intensive glycemic control and the prevention of cardiovascular events: implications of the ACCORD, ADVANCE, and VA diabetes trials: a position statement of the American Diabetes Association and a scientific statement of the American College of Cardiology Foundation and the American Heart Association.
Circulation 2009;119(2):351-7.
2009: Johanna R Klaus; Barry E Hurwitz; Maria M Llabre; Jay S Skyler; Ronald B Goldberg; Jennifer B Marks; Martin Bilsker; Neil Schneiderman
Central obesity and insulin resistance in the cardiometabolic syndrome: pathways to preclinical cardiovascular structure and function.
Journal of the cardiometabolic syndrome 2009;4(2):63-71.
2009: Wendy S Lane; Elaine K Cochran; Jeffrey A Jackson; Jamie L Scism-Bacon; Ilene B Corey; Irl B Hirsch; Jay S Skyler
High-dose insulin therapy: is it time for U-500 insulin?
Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists 2009;15(1):71-9.
2009: Jay S Skyler; Richard Bergenstal; Robert O Bonow; John B Buse; Prakash Deedwania; Edwin A M Gale; Barbara V Howard; M Sue Kirkman; Mikhail Kosiborod; Peter Reaven; Robert S Sherwin
Intensive glycemic control and the prevention of cardiovascular events: implications of the ACCORD, ADVANCE, and VA diabetes trials: a position statement of the American Diabetes Association and a scientific statement of the American College of Cardiology Foundation and the American Heart Association.
Diabetes care 2009;32(1):187-92.
2008: Jay S Skyler
Update on worldwide efforts to prevent type 1 diabetes.
Annals of the New York Academy of Sciences 2008;1150():190-6.
2008: Jay S Skyler; Carla J Greenbaum; John M Lachin; Ellen Leschek; Lisa Rafkin-Mervis; Peter Savage; Lisa M. Spain
Type 1 Diabetes TrialNet--an international collaborative clinical trials network.
Annals of the New York Academy of Sciences 2008;1150():14-24.
2008: Jay S Skyler; Priscilla A Hollander; Lois Jovanovic; Sol Klioze; Alan Krasner; Richard J Riese; Joann Reis; Pamela Schwartz; William Duggan
Safety and efficacy of inhaled human insulin (Exubera) during discontinuation and readministration of therapy in adults with type 1 diabetes: A 3-year randomized controlled trial.
Diabetes research and clinical practice 2008;82(2):238-46.
2008: Jay S Skyler
Latent autoimmune diabetes in adults: the search for interventions continues.
Nature clinical practice. Endocrinology & metabolism 2008;4(11):600-1.
2008: Jay M Sosenko; Jerry P Palmer; Lisa Rafkin-Mervis; Jeffrey P Krischer; David Cuthbertson; Della Matheson; Jay S Skyler
Glucose and C-peptide changes in the perionset period of type 1 diabetes in the Diabetes Prevention Trial-Type 1.
Diabetes care 2008;31(11):2188-92.
2008: Jennifer Sherr; Jay M Sosenko; Jay S Skyler; Kevan C Herold
Prevention of type 1 diabetes: the time has come.
Nature clinical practice. Endocrinology & metabolism 2008;4(6):334-43.
2008: Stephen W Ponder; Jay S Skyler; Davida F Kruger; Della Matheson; Bruce W Brown
Unexplained hyperglycemia in continuous subcutaneous insulin infusion: evaluation and treatment.
The Diabetes educator 2008;34(2):327-33.
2008: Jay M Sosenko; Jeffrey P Krischer; Jerry P Palmer; Jeffrey Mahon; Catherine Cowie; Carla J Greenbaum; David Cuthbertson; John M Lachin; Jay S Skyler
A risk score for type 1 diabetes derived from autoantibody-positive participants in the diabetes prevention trial-type 1.
Diabetes care 2008;31(3):528-33.
2008: Jay S Skyler
Thirty years of diabetes care: reflections on the beginning.
Diabetes care 2008;31(1):183-4.
2007: Jay S Skyler
Pulmonary insulin delivery--state of the art 2007.
Diabetes technology & therapeutics 2007;9 Suppl 1():S1-3.
2007: Jay S Skyler
Prediction and prevention of type 1 diabetes: progress, problems, and prospects.
Clinical pharmacology and therapeutics 2007;81(5):768-71.
2007: Jay S Skyler
Cellular therapy for type 1 diabetes: has the time come?
JAMA : the journal of the American Medical Association 2007;297(14):1599-600.
2007: Jay S Skyler; Lois Jovanovic; Sol Klioze; Joann Reis; William Duggan
Two-year safety and efficacy of inhaled human insulin (Exubera) in adult patients with type 1 diabetes.
Diabetes care 2007;30(3):579-85.
2007: Barry E Hurwitz; Johanna R Klaus; Maria M Llabre; Alex Gonzalez; Peter J Lawrence; Kevin J Maher; Jeffrey Greeson; Marianna K Baum; Gail Shor-Posner; Jay S Skyler; Neil Schneiderman
Suppression of human immunodeficiency virus type 1 viral load with selenium supplementation: a randomized controlled trial.
Archives of internal medicine 2007;167(2):148-54.
2007: Jay M Sosenko; Jerry P Palmer; Carla J Greenbaum; Jeffrey Mahon; Catherine Cowie; Jeffrey P Krischer; H Peter Chase; Neil H White; Bruce Buckingham; Kevan C Herold; David Cuthbertson; Jay S Skyler
Increasing the accuracy of oral glucose tolerance testing and extending its application to individuals with normal glucose tolerance for the prediction of type 1 diabetes: the Diabetes Prevention Trial-Type 1.
Diabetes care 2007;30(1):38-42.
2006: Jay M Sosenko; Jerry P Palmer; Carla J Greenbaum; Jeffrey Mahon; Catherine Cowie; Jeffrey P Krischer; H Peter Chase; Neil H White; Bruce Buckingham; Kevan C Herold; David Cuthbertson; Jay S Skyler
Patterns of metabolic progression to type 1 diabetes in the Diabetes Prevention Trial-Type 1.
Diabetes care 2006;29(3):643-9.
2005: Jay S Skyler
Pulmonary insulin update.
Diabetes technology & therapeutics 2005;7(5):834-9.
2005: Jay S Skyler; Ruth S Weinstock; Philip Raskin; Jean-François Yale; Eugene Barrett; John E Gerich; Hertzel C Gerstein
Use of inhaled insulin in a basal/bolus insulin regimen in type 1 diabetic subjects: a 6-month, randomized, comparative trial.
Diabetes care 2005;28(7):1630-5.
2005: Jay S Skyler; Jeffrey P Krischer; Joseph I Wolfsdorf; Catherine Cowie; Jerry P Palmer; Carla J Greenbaum; David Cuthbertson; Lisa Rafkin-Mervis; H Peter Chase; Ellen Leschek
Effects of oral insulin in relatives of patients with type 1 diabetes: The Diabetes Prevention Trial--Type 1.
Diabetes care 2005;28(5):1068-76.
2004: Jay S Skyler
Diabetes mellitus: pathogenesis and treatment strategies.
Journal of medicinal chemistry 2004;47(17):4113-7.
2004: Barry E Hurwitz; Nancy Klimas; Maria M Llabre; Kevin J Maher; Jay S Skyler; Martin Bilsker; Shvawn McPherson-Baker; Peter J Lawrence; Arthur LaPerriere; Jeffrey Greeson; Johanna R Klaus; Rasha Lawrence; Neil Schneiderman
HIV, metabolic syndrome X, inflammation, oxidative stress, and coronary heart disease risk : role of protease inhibitor exposure.
Cardiovascular toxicology 2004;4(3):303-16.
2004: Jerry P Palmer; G Alexander Fleming; Carla J Greenbaum; Kevan C Herold; Lisa D Jansa; Hubert Kolb; John M Lachin; Kenneth S Polonsky; Paolo Pozzilli; Jay S Skyler; Michael W Steffes
C-peptide is the appropriate outcome measure for type 1 diabetes clinical trials to preserve beta-cell function: report of an ADA workshop, 21-22 October 2001.
Diabetes 2004;53(1):250-64.
2002: Jay S Skyler; Carolyn Oddo
Diabetes trends in the USA.
Diabetes/metabolism research and reviews 2002;18 Suppl 3():S21-6.
2001: Jay S Skyler
Microvascular complications. Retinopathy and nephropathy.
Endocrinology and metabolism clinics of North America 2001;30(4):833-56.
2001: R Z Goldstein; Barry E Hurwitz; Maria M Llabre; Neil Schneiderman; Miriam Gutt; Jay S Skyler; R J Prineas; Richard P Donahue
Modeling preclinical cardiovascular risk for use in epidemiologic studies: Miami community health study.
American journal of epidemiology 2001;154(8):765-76.
2001: W T Cefalu; Jay S Skyler; Ione A Kourides; William H Landschulz; C C Balagtas; S Cheng; Robert A Gelfand
Inhaled human insulin treatment in patients with type 2 diabetes mellitus.
Annals of internal medicine 2001;134(3):203-7.
2001: Jay S Skyler; W T Cefalu; Ione A Kourides; William H Landschulz; C C Balagtas; S L Cheng; Robert A Gelfand
Efficacy of inhaled human insulin in type 1 diabetes mellitus: a randomised proof-of-concept study.
Lancet 2001;357(9253):331-5.
2000: Miriam Gutt; Catherine Lucy Davis; S B Spitzer; Maria M Llabre; Mahendra Kumar; E M Czarnecki; Neil Schneiderman; Jay S Skyler; Jennifer B Marks
Validation of the insulin sensitivity index (ISI(0,120)): comparison with other measures.
Diabetes research and clinical practice 2000;47(3):177-84.
2000: Arlan Rosenbloom; Desmond A Schatz; Jeffrey P Krischer; Jay S Skyler; Dorothy J Becker; R E Laporte; Ingrid M Libman; Massimo Pietropaolo; H M Dosch; L Finberg; A Muir; William V Tamborlane; M Grey; J H Silverstein; John I Malone
Therapeutic controversy: prevention and treatment of diabetes in children.
The Journal of clinical endocrinology and metabolism 2000;85(2):494-522.
2000: Jay S Skyler
The economic burden of diabetes and the benefits of improved glycemic control: the potential role of a continuous glucose monitoring system.
Diabetes technology & therapeutics 2000;2 Suppl 1():S7-12.
2000: B Feldman; G McGarraugh; A Heller; N Bohannon; Jay S Skyler; E DeLeeuw; D Clarke
FreeStyle: a small-volume electrochemical glucose sensor for home blood glucose testing.
Diabetes technology & therapeutics 2000;2(2):221-9.
1999: Catherine Lucy Davis; Miriam Gutt; Maria M Llabre; Jennifer B Marks; Mary J O'Sullivan; JoNell Potter; J L Landel; Mahendra Kumar; Neil Schneiderman; Marc D. Gellman; Jay S Skyler
History of gestational diabetes, insulin resistance and coronary risk.
Journal of diabetes and its complications 1999;13(4):216-23.
1999: Richard P Donahue; Ronald J Prineas; R D Donahue; P Zimmet; JA Bean; Maximilian P de Courten; G Collier; Ronald B Goldberg; Jay S Skyler; Neil Schneiderman
Is fasting leptin associated with insulin resistance among nondiabetic individuals? The Miami Community Health Study.
Diabetes care 1999;22(7):1092-6.
1999: Richard P Donahue; P Zimmet; JA Bean; M Decourten; R A DeCarlo Donahue; G Collier; Ronald B Goldberg; Ronald J Prineas; Jay S Skyler; Neil Schneiderman
Cigarette smoking, alcohol use, and physical activity in relation to serum leptin levels in a multiethnic population: The Miami Community Health Study.
Annals of epidemiology 1999;9(2):108-13.
1999: Sarosh J Motivala; Barry E Hurwitz; Annette M. LaGreca; Maria M Llabre; Jennifer B Marks; Jay S Skyler; Neil Schneiderman
Aberrant parasympathetic and hemodynamic function distinguishes a subgroup of psychologically distressed individuals with asymptomatic type-I diabetes mellitus.
International journal of behavioral medicine 1999;6(1):78-94.
1999: Jay S Skyler
New diabetes criteria and clinical implications.
Drugs 1999;58 Suppl 1():1-2; discussion 75-82.
1998: Jay S Skyler
Simplifying the diagnosis of diabetes mellitus.
American family physician 1998;58(6):1290-2.
1998: Jay S Skyler
Targeted glycemic control in type 2 diabetes.
The Journal of the Florida Medical Association 1998;85(2):7-15.
1998: Alex Rabinovitch; Jay S Skyler
Prevention of type 1 diabetes.
The Medical clinics of North America 1998;82(4):739-55.
1998: Richard P Donahue; Ronald J Prineas; JA Bean; R A deCarlo Donahue; Ronald B Goldberg; Jay S Skyler; Neil Schneiderman
The relation of fasting insulin to blood pressure in a multiethnic population: the Miami Community Health Study.
Annals of epidemiology 1998;8(4):236-44.
1998: George W Burke; Gaetano Ciancio; Rodolfo Alejandro; David Roth; Camillo Ricordi; Jay S Skyler; Andreas G Tzakis; Joshua Miller
Cholesterol control: long-term benefit of pancreas-kidney transplantation with FK 506 immunosuppression.
Transplantation proceedings 1998;30(2):513-4.
1997: Jay S Skyler
Glucose control in type 2 diabetes mellitus.
Annals of internal medicine 1997;127(9):837-9.
1997: Jay S Skyler
Tactics for type I diabetes.
Endocrinology and metabolism clinics of North America 1997;26(3):647-57.
1997: George W Burke; Camillo Ricordi; T Karatzas; Manuel R Carreno; M Markou; Robert E Cirocco; Gaetano Ciancio; T Qian; Gennaro Selvaggi; Rodolfo Alejandro; Jay S Skyler; David Roth; Andreas G Tzakis; Joshua Miller
Donor bone marrow infusion in simultaneous pancreas/kidney transplantation with OKT3 induction: evidence for augmentation of chimerism.
Transplantation proceedings 1997;29(1-2):1207-8.
1997: Jay S Skyler
Insulin therapy in type II diabetes: who needs it, how much of it, and for how long?
Postgraduate medicine 1997;101(2):85-90, 92-4, 96.
1997: S L Weber; P J Gkonos; Jay S Skyler
Combined octreotide and insulin therapy in acromegaly.
Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists 1997;3(1):19-21.
1996: Richard P Donahue; R A Donahue; Ronald J Prineas; J Bean; Miriam Gutt; Jay S Skyler; Neil Schneiderman
Insulin sensitivity and blood pressure in a biethnic sample: the Miami Community Health Study.
Journal of clinical epidemiology 1996;49(8):859-64.
1996: Jay S Skyler
Diabetic complications. The importance of glucose control.
Endocrinology and metabolism clinics of North America 1996;25(2):243-54.
1996: D C Robbins; L Andersen; R Bowsher; R Chance; B Dinesen; B Frank; R Gingerich; D Goldstein; H M Widemeyer; Steven M Haffner; C N Hales; L Jarett; Kenneth S Polonsky; D Porte; Jay S Skyler; G Webb; K Gallagher
Report of the American Diabetes Association's Task Force on standardization of the insulin assay.
Diabetes 1996;45(2):242-56.
1996: Richard P Donahue; Ronald J Prineas; R DeCarlo Donahue; J A Bean; Jay S Skyler
The female 'insulin advantage' in a biracial cohort: results from the Miami Community Health Study.
International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity 1996;20(1):76-82.
1995: Jay S Skyler; Jennifer B Marks; Neil Schneiderman
Hypertension in patients with diabetes mellitus.
American journal of hypertension 1995;8(12 Pt 2):100s-105s.
1995: George W Burke; Rodolfo Alejandro; Gaetano Ciancio; Jose Nery; David Roth; R Shapiro; V Scantlebury; Jay S Skyler; Camillo Ricordi; Andreas G Tzakis
The use of FK506 in simultaneous pancreas/kidney transplantation: rescue, induction, and maintenance immunosuppression.
Transplantation proceedings 1995;27(6):3123-4.
1995: George W Burke; Rodolfo Alejandro; David Roth; J Colona; N Contreras; Gaetano Ciancio; Jay S Skyler; Camillo Ricordi; Jose Nery; Andreas G Tzakis
Use of FK 506 in simultaneous pancreas/kidney transplantation: lack of impairment of glycemic or lipid metabolism.
Transplantation proceedings 1995;27(6):3119-20.
1994: L C Deeb; Jay S Skyler
Upgrading diabetes therapy. Now that we know it matters.
The Journal of the Florida Medical Association 1994;81(9):599-602.
1994: George W Burke; Rodolfo Alejandro; Jose Nery; David Roth; Jay S Skyler; Camillo Ricordi; Gaetano Ciancio; Joshua Miller
Combined kidney/pancreas transplantation in diabetes mellitus.
The Journal of the Florida Medical Association 1994;81(5):339-43.
1994: Jerry Radziuk; Susan Pye; D E Seigler; Jay S Skyler; R Offord; G Davies
Splanchnic and systemic absorption of intraperitoneal insulin using a new double-tracer method.
The American journal of physiology 1994;266(5 Pt 1):E750-9.
1994: Barry E Hurwitz; R E Quillian; Jennifer B Marks; Neil Schneiderman; R F Agramonte; C R Freeman; Annette M. LaGreca; Jay S Skyler
Resting parasympathetic status and cardiovascular response to orthostatic and behavioral challenges in type I insulin-dependent diabetes mellitus.
International journal of behavioral medicine 1994;1(2):137-62.
1994: George W Burke; Robert E Cirocco; M Markou; R F Agramonte; A Rabinovitch; Joshua Miller; Jay S Skyler
Effect of cyclosporine A on serum tumor necrosis factor alpha in new-onset type I (insulin-dependent) diabetes mellitus.
Journal of diabetes and its complications 1994;8(1):40-4.
1993: Jay S Skyler
Human insulin after 10 years.
Diabetes care 1993;16 Suppl 3():1-3.
1993: Jay S Skyler; T J Lorenz; S Schwartz; G S Eisenbarth; D Einhorn; Jerry P Palmer; Jennifer B Marks; Carla J Greenbaum; E A Saria; V Byers
Effects of an anti-CD5 immunoconjugate (CD5-plus) in recent onset type I diabetes mellitus: a preliminary investigation. The CD5 Diabetes Project Team.
Journal of diabetes and its complications 1993;7(4):224-32.
1993: Jay S Skyler
SSCI presidential address: challenges of the future.
The American journal of the medical sciences 1993;306(1):5-9.
1993: Jay S Skyler
The winds of change.
Diabetes 1993;42(5):637-42.
1992: D E Seigler; G M Olsson; Jay S Skyler
Morning versus bedtime isophane insulin in type 2 (non-insulin dependent) diabetes mellitus.
Diabetic medicine : a journal of the British Diabetic Association 1992;9(9):826-33.
1992: Irl B Hirsch; R Farkas-Hirsch; J S Herbst; Jay S Skyler
The effect of ejaculation on albumin excretion rate.
Journal of diabetes and its complications 1992;6(3):163-5.
1992: Jay S Skyler; Alex Rabinovitch
Cyclosporine in recent onset type I diabetes mellitus. Effects on islet beta cell function. Miami Cyclosporine Diabetes Study Group.
Journal of diabetes and its complications 1992;6(2):77-88.
1992: Jay S Skyler
Is tight blood sugar control effective and justified? Affirmative.
Hospital practice (Office ed.) 1992;27 Suppl 1():17-20; discussion 24-5.
1991: A Peckerman; Patrice G Saab; Philip M McCabe; Jay S Skyler; RW Winters; Maria M Llabre; Neil Schneiderman
Blood pressure reactivity and perception of pain during the forehead cold pressor test.
Psychophysiology 1991;28(5):485-95.
1991: Jay S Skyler
Strategies in diabetes mellitus. Start of a new era.
Postgraduate medicine 1991;89(6):45-6, 49, 53-6 passim.
1991: R Martinez; B Rietberg; Jay S Skyler; J R Oster; G O Perez
Effect of hyperkalemia on insulin secretion.
Experientia 1991;47(3):270-2.
1991: Jennifer B Marks; Jay S Skyler
Clinical review 17: Immunotherapy of type I diabetes mellitus.
The Journal of clinical endocrinology and metabolism 1991;72(1):3-9.
1990: Irl B Hirsch; R Farkas-Hirsch; Jay S Skyler
Intensive insulin therapy for treatment of type I diabetes.
Diabetes care 1990;13(12):1265-83.
1990: Richard P Donahue; Jay S Skyler; Neil Schneiderman; Ronald J Prineas
Hyperinsulinemia and elevated blood pressure: cause, confounder, or coincidence?
American journal of epidemiology 1990;132(5):827-36.
1989: H Kolb; J F Bach; G S Eisenbarth; L C Harrison; N K Maclaren; P Pozzilli; Jay S Skyler; C R Stiller
Criteria for immune trials in type I diabetes.
Lancet 1989;2(8664):686.
1989: W Satin; Annette M. LaGreca; M A Zigo; Jay S Skyler
Diabetes in adolescence: effects of multifamily group intervention and parent simulation of diabetes.
Journal of pediatric psychology 1989;14(2):259-75.
1989: Jay S Skyler
Intensive insulin therapy: a personal and historical perspective.
The Diabetes educator 1989;15(1):33-9.
1988: Jay S Skyler
Insulin pharmacology.
The Medical clinics of North America 1988;72(6):1337-54.
1988: M T Gadia; Jay S Skyler; Jay M Sosenko
The association between heart rate and glycemia in adult diabetic subjects.
Diabetes research and clinical practice 1988;5(1):25-9.
1988: A J Boulton; R G Cutfield; D Abouganem; E Angus; Harry W Flynn; Jay S Skyler; N S Penneys
Necrobiosis lipoidica diabeticorum: a clinicopathologic study.
Journal of the American Academy of Dermatology 1988;18(3):530-7.
1988: Jay M Sosenko; A J Boulton; M T Gadia; J D Ward; Jay S Skyler
The association between symptomatic sensory neuropathy and body stature in diabetic patients.
Diabetes research and clinical practice 1988;4(2):95-8.
1987: Jay M Sosenko; M T Gadia; N Natori; Doraiswami Ayyar; L B Ramos; Jay S Skyler
Neurofunctional testing for the detection of diabetic peripheral neuropathy.
Archives of internal medicine 1987;147(10):1741-4.
1987: Jay S Skyler
Immune intervention studies in insulin-dependent diabetes mellitus.
Diabetes/metabolism reviews 1987;3(4):1017-35.
1987: M T Gadia; N Natori; L B Ramos; Doraiswami Ayyar; Jay S Skyler; Jay M Sosenko
Influence of height on quantitative sensory, nerve-conduction, and clinical indices of diabetic peripheral neuropathy.
Diabetes care 1987;10(5):613-6.
1987: Jay S Skyler
Why control blood glucose? Influence on chronic complications of diabetes.
Pediatric annals 1987;16(9):713, 716-9, 723-4.
1987: Jay S Skyler; A Rabinovitch
Etiology and pathogenesis of insulin dependent diabetes mellitus.
Pediatric annals 1987;16(9):682-3, 686-92.
1987: Jay S Skyler
Insulin-dependent diabetes mellitus. Flexibility in contemporary management.
Postgraduate medicine 1987;81(6):163-9, 172-4.
1987: R Harris; M W Linn; Jay S Skyler; R Sandifer
Development of the diabetes health belief scale.
The Diabetes educator 1987;13(3):292-7.
1986: Jay S Skyler
Lessons from studies of insulin pharmacokinetics.
Diabetes care 1986;9(6):666-8.
1986: Jay M Sosenko; D B Kubrusly; Ronald B Goldberg; Arthur Fournier; S L Hsia; M T Gadia; Jay S Skyler
High-density lipoprotein and glycosylated hemoglobin in nondiabetic individuals.
Archives of internal medicine 1986;146(8):1521-4.
1986: A J Boulton; D B Kubrusly; J H Bowker; M T Gadia; L Quintero; D M Becker; Jay S Skyler; Jay M Sosenko
Impaired vibratory perception and diabetic foot ulceration.
Diabetic medicine : a journal of the British Diabetic Association 1986;3(4):335-7.
1986: Jay M Sosenko; M T Gadia; Arthur Fournier; Mark T O'Connell; M C Aguiar; Jay S Skyler
Body stature as a risk factor for diabetic sensory neuropathy.
The American journal of medicine 1986;80(6):1031-4.
1986: Arthur Fournier; M T Gadia; D B Kubrusly; Jay S Skyler; Jay M Sosenko
Blood pressure, insulin, and glycemia in nondiabetic subjects.
The American journal of medicine 1986;80(5):861-4.
1986: A J Boulton; J H Bowker; M Gadia; R Lemerman; K Caswell; Jay S Skyler; Jay M Sosenko
Use of plaster casts in the management of diabetic neuropathic foot ulcers.
Diabetes care 1986;9(2):149-52.
1986: Jay S Skyler
Control of diabetes during pregnancy: 1985.
JAMA : the journal of the American Medical Association 1986;255(5):647-8.
1985: Arlan Rosenbloom; J I Malone; A D Morrison; Jay S Skyler
Screening for diabetes mellitus.
The Journal of the Florida Medical Association 1985;72(12):1033-7.
1985: Jay M Sosenko; A J Boulton; D B Kubrusly; J K Weintraub; Jay S Skyler
The vibratory perception threshold in young diabetic patients: associations with glycemia and puberty.
Diabetes care 1985;8(6):605-7.
1985: Ronald B Goldberg; M L Reeves; D E Seigler; E A Ryan; N Miller; S L Hsia; Jay S Skyler
Lack of a persistent reduction in serum lipid and apoprotein levels in insulin-dependent diabetic patients receiving intensified insulin treatment.
Acta diabetologica latina 1985;22(2):93-101.
1985: E A Ryan; Mary J O'Sullivan; Jay S Skyler
Insulin action during pregnancy. Studies with the euglycemic clamp technique.
Diabetes 1985;34(4):380-9.
1984: Jay S Skyler; C M Beatty; Ronald B Goldberg
Managing diabetes: an updated look at diet.
Geriatrics 1984;39(7):57-60, 64-66, 68.
1984: Bruce B Duncan; Maria Inês Schmidt; Jay S Skyler; G J Ellis; A Keller; M H Rathjens
The flashlight test lacks validity as a screen for nocturnal hypoglycemia.
Diabetes care 1984;7(3):269-72.
1984: M L Reeves; D E Seigler; Doraiswami Ayyar; Jay S Skyler
Medial plantar sensory response. Sensitive indicator of peripheral nerve dysfunction in patients with diabetes mellitus.
The American journal of medicine 1984;76(5):842-6.
1984: Jay S Skyler
Non-insulin-dependent diabetes mellitus: a clinical strategy.
Diabetes care 1984;7 Suppl 1():118-29.
1983: Jay S Skyler
Dietary planning in insulin-dependent diabetes mellitus.
Pediatric annals 1983;12(9):652-7.
1983: E A Ryan; J Miller; Jay S Skyler
Finger sepsis: possible complication of self monitoring of blood glucose concentrations.
British medical journal (Clinical research ed.) 1983;286(6378):1614-5.
1983: M W Linn; B S Linn; Jay S Skyler; J Jensen
Stress and immune function in diabetes mellitus.
Clinical immunology and immunopathology 1983;27(2):223-33.
1982: Jay S Skyler
Management of diabetic retinopathy.
JAMA : the journal of the American Medical Association 1982;248(22):2970-1.
1982: Jay S Skyler
Human insulin of recombinant DNA origin: clinical potential.
Diabetes care 1982;5 Suppl 2():181-6.
1982: Jay S Skyler
Self-monitoring of blood glucose.
The Medical clinics of North America 1982;66(6):1227-50.
1982: Jay S Skyler
Type I diabetes . . . regimens, targets, and caveats.
Diabetes care 1982;5(5):547-52.
1982: Jay S Skyler
Type II diabetes: toward improved understanding and rational therapy.
Diabetes care 1982;5(4):447-50.
1982: Jay S Skyler
Diabetic retinopathy.
JAMA : the journal of the American Medical Association 1982;247(23):3246-7.
1982: D E Seigler; Annette M. LaGreca; W S Citrin; M L Reeves; Jay S Skyler
Psychological effects of intensification of diabetic control.
Diabetes care 1982;5 Suppl 1():19-23.
1982: Jay S Skyler; D E Seigler; M L Reeves
A comparison of insulin regimens in insulin-dependent diabetes mellitus.
Diabetes care 1982;5 Suppl 1():11-8.
1982: D E Seigler; M L Reeves; Jay S Skyler
Lack of effect of improved glycemic control on C-peptide secretion in patients without residual B-cell function.
Diabetes care 1982;5(3):334-6.
1982: M L Reeves; D E Seigler; E A Ryan; Jay S Skyler
Glycemic control in insulin-dependent diabetes mellitus. Comparison of outpatient intensified conventional therapy with continuous subcutaneous insulin infusion.
The American journal of medicine 1982;72(4):673-80.
1982: Jay S Skyler; D E Seigler; M L Reeves
Optimizing pumped insulin delivery.
Diabetes care 1982;5(2):135-9.
1982: L S Lieberman; Arlan Rosenbloom; B O'Malley; J I Malone; Jay S Skyler
Institutionally-based diabetes educational services for patients and their families in Florida.
The Journal of the Florida Medical Association 1982;69(1):23-31.
1981: Jay S Skyler
Psychological issues in diabetes.
Diabetes care 1981;4(6):656-7.
1981: Jay S Skyler
Evidence, implications, and corollaries.
Diabetes care 1981;4(5):573-5, 1214.
1981: M L Reeves; S E Forhan; Jay S Skyler; C M Peterson
Comparison of methods for blood glucose monitoring.
Diabetes care 1981;4(3):404-6.
1981: Jay S Skyler; F A Neelson
An algebra for adiposity?
Diabetes care 1981;4(2):328-9.
1981: Jay S Skyler; D L Skyler; D E Seigler; Mary J O'Sullivan
Algorithms for adjustment of insulin dosage by patients who monitor blood glucose.
Diabetes care 1981;4(2):311-8.
1981: Jay S Skyler; E F Pfeiffer; S Raptis; G C Viberti
Biosynthetic human insulin: progress and prospects.
Diabetes care 1981;4(2):140-3.
1981: Jay S Skyler; G F Cahill
Diabetes mellitus: progress and directions.
The American journal of medicine 1981;70(1):101-4.
1980: M W Linn; B S Linn; Jay S Skyler; R Harris
The importance of self-assessed health in patients with diabetes.
Diabetes care 1980;3(5):599-606.
1980: Jay S Skyler
A plethora of insulins.
Diabetes care 1980;3(5):638-9.
1980: D C Jimerson; R M Post; D P van Kammen; Jay S Skyler; G L Brown; W E Bunney
Cerebrospinal fluid cortisol levels in depression and schizophrenia.
The American journal of psychiatry 1980;137(8):979-80.
1980: W Citrin; G J Ellis; Jay S Skyler
Glycosylated hemoglobin: a tool in identifying psychological problems?
Diabetes care 1980;3(4):563-4.
1980: Jay S Skyler; Mary J O'Sullivan; K K Holsinger
The relationship between maternal glycemia and macrosomia.
Diabetes care 1980;3(3):433-4.
1980: Jay S Skyler; K G Alberti
Clinical assessment of metabolic control in insulin-dependent diabetes mellitus.
Diabetes care 1980;3(2):369-70.
1980: Jay S Skyler; Mary J O'Sullivan; E G Robertson; D L Skyler; K K Holsinger; I A Lasky; A G McLeod; Gene Burkett; Daniel Mintz
Blood glucose control during pregnancy.
Diabetes care 1980;3(1):69-76.
1979: Jay S Skyler
The spectrum of insulin resistance.
Diabetes care 1979;2(3):319-22.
1979: Jay S Skyler
Diabetes and exercise: clinical implications.
Diabetes care 1979;2(3):307-11.
1979: Jay S Skyler
Thoughts along the way.
Diabetes care 1979;2(1):58-9.
1979: Jay S Skyler; G J Ellis; D L Skyler; I A Lasky; F L Lebovitz
Instructing patients in making alterations in insulin dosage.
Diabetes care 1979;2(1):39-45.
1978: Jay S Skyler
The UGDP and insulin therapy.
Diabetes care 1978;1(5):328-9.
1978: Jay S Skyler
Sulfonylurea drugs 1978.
Diabetes care 1978;1(3):205-6.
1978: Jay S Skyler
"Control" and diabetic complications.
Diabetes care 1978;1(3):204-5.
1978: Jay S Skyler; I A Lasky; D L Skyler; E G Robertson; Daniel Mintz
Home blood glucose monitoring as an aid in diabetes management.
Diabetes care 1978;1(3):150-7.
1978: Jay S Skyler
Lipids, diet, diabetes, and atherogenesis.
Diabetes care 1978;1(2):138-9.
1978: G W Blankenship; Jay S Skyler
Diabetic retinopathy: a general survey.
Diabetes care 1978;1(2):127-37.
1978: Daniel Mintz; Jay S Skyler; R A Chez
Diabetes mellitus and pregnancy.
Diabetes care 1978;1(1):49-63.
1978: F L Lebovitz; G J Ellis; Jay S Skyler
Performance of technical skills of diabetes management: increased independence after a camp experience.
Diabetes care 1978;1(1):23-6.
1977: Jay S Skyler; A Chrambach; C H Li
Quantitative polyacrylamide gel electrophoresis and specific activities of human somatotropin and its derivatives.
Biochimica et biophysica acta 1977;491(2):566-72.
1977: Jay S Skyler; A D Rogol; W Lovenberg; R A Knazek
Characterization of growth hormone and prolactin produced by human pituitary in culture.
Endocrinology 1977;100(2):283-91.
1977: Jay S Skyler; G Baumann; A Chrambach
A catalogue of isohormones of human growth hormone based on quantitative polyacrylamide gel electrophoresis.
Acta endocrinologica. Supplementum 1977;211():5-40.
1976: D C Jimerson; R M Post; Jay S Skyler; W E Bunney
Prolactin in cerebrospinal fluid and dopamine function in man.
The Journal of pharmacy and pharmacology 1976;28(11):845-6.
1976: S Slater; C E de La Vega; Jay S Skyler; D L Murphy
Plasma prolactin stimulation by fenfluramine and amphetamine.
Psychopharmacology bulletin 1976;12(4):26-7.
1976: D C Jimerson; R M Post; Jay S Skyler; W E Bunney
A preliminary report: neuroendocrine effects of dopamine and norepinephrine receptor stimulators.
Psychopharmacology bulletin 1976;12(4):24-6.
1976: H J Zweerink; E M Morgan; Jay S Skyler
Reovirus morphogenesis: characterization of subviral particles in infected cells.
Virology 1976;73(2):442-53.
1976: R A Knazek; Jay S Skyler; P M Guillino
Secretion of human prolactin in vitro.
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.) 1976;151(3):561-64.
1975: W Kempner; B C Newborg; R L Peschel; Jay S Skyler
Treatment of massive obesity with rice/reduction diet program. An analysis of 106 patients with at least a 45-kg weight loss.
Archives of internal medicine 1975;135(12):1575-84.
1975: J M Feldman; C H Bivens; Jay S Skyler; H E Lebovitz
Effect of cyproheptadine administration on insulin secretion in acromegalic, diabetic and normal subjects.
Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et métabolisme 1975;7(4):279-83.
1974: J Dranov; Jay S Skyler; J C Gunnells
Malignant hypertension. Current modes of therapy.
Archives of internal medicine 1974;133(5):791-801.
1974: Jay S Skyler
Walter Kempner. A biographical note.
Archives of internal medicine 1974;133(5):752-5.
1974: Jay S Skyler; G J Ellis; C H Bivens
Carolinas' camp for diabetic children. II. Descriptive features of a camper population with emphasis on complications.
North Carolina medical journal 1974;35(1):29-32.
1974: Jay S Skyler; F A Neelon; W J Arnold; W N Kelly; H E Lebovitz
Growth retardation in the Lesch-Nyhan syndrome.
Acta endocrinologica 1974;75(1):3-10.
1973: Jay S Skyler; G J Ellis; H K Delcher
Carolinas' camp for diabetic children. I. Report of first five years of operation.
North Carolina medical journal 1973;34(12):935-8.
1973: Jay S Skyler
Differential certification of physician's assistants.
Archives of internal medicine 1973;132(2):291.
1973: N M Kredich; Jay S Skyler; L J Foote
Antibodies to native DNA in systemic lupus erythematosus. A technique of rapid and quantitative determination.
Archives of internal medicine 1973;131(5):639-44.
1971: Jay S Skyler
Symposium on social issues and medicine. Introductory remarks.
Archives of internal medicine 1971;127(1):49-50.
1971: Jay S Skyler
Symposium on social issues and medicine. Concluding remarks.
Archives of internal medicine 1971;127(1):110.
1969: Jay S Skyler
Detecting hypothyroidism.
Lancet 1969;1(7588):259.
1968: Jay S Skyler
Medical-student dissent deplored.
The New England journal of medicine 1968;278(11):624-5.